Genesis Medtech Acquires Jc Medical, Creates New Structural Heart Franchise
Feb 05, 2022•almost 4 years ago
Acquiring Company
Genesis Medtech Group
Acquired Company
JC Medical
Health Care
Description
Genesis MedTech Group (Genesis or Group) has completed the acquisition of JC Medical (JCM), a structural heart company that is primarily engaged in the design and development of transcatheter valve replacement products for the minimally invasive treatment of structural heart diseases. The acquisition means that Genesis will be able to add J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device for both aortic regurgitation and stenosis patients, to its product portfolio. This addition will greatly improve Group's ability to better meet the needs of patients, interventional cardiologists, and cardiac surgeons.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed